Womens Health Diagnostics Market Expected to Reach $36.3 Billion by 2030—Allied Market Research

According to a new report published by Allied Market Research, titled, “Womens Health Diagnostics Market," The womens health diagnostics market size was valued at $19.2 billion in 2020, and is estimated to reach $36.3 billion by 2030, growing at a CAGR of 6.9% from 2021 to 2030.

Women’s health diagnostics system improves the women’s health by screening, diagnosing, and monitoring the disease conditions, such as different types of cancer, infertility, and other diseases. The cervical cancer screening supports infertility, prenatal testing, and pregnancy care to breast and ovarian cancer diagnosis to managing bone health & diagnostics. Increase in need for the diagnostics of women’s health-related diseases is considered to be more susceptible to certain disorders, such as osteoporosis, menstrual disorders, cancer, and autoimmune diseases. The major diseases include, menopause, infertility, polycystic ovarian syndrome, and certain cancers, such as breast cancer and cervical cancer, as well as urological disorders. The medical diagnostics devices and tests help to improve the women’s health and accurate treatment against disease.

The key factor that drives the growth of market is rise in the prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer. Breast cancer is the most commonly occurring cancer in women and the second most common cancer globally. Moreover, high cost of imaging & monitoring system and lack of skilled professionals are responsible for hampering the womens health diagnostics market growth. Moreover, due to miniaturization of ultrasound devices, untapped emerging economics in developing nations, such as Brazil, India, and UK, have been undergoing rapid changes in terms of healthcare investments and infrastructure, which create lucrative opportunities for key market players anticipated to boost the growth of market.

The womens health diagnostics industry is segmented on the basis of type, end user, and region. On the basis of type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The devices segment is further segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems segment is further segmented into ultrasound device, mammography systems & other. Ultrasound imaging systems is further sub segmented into OB/GYN ultrasound and breast ultrasound. Mammography systems are further categorized as analog mammography systems, digital mammography systems, and breast tomosynthesis system. The diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening & carrier testing include tests for cystic fibrosis and other diseases. The pregnancy & ovulation testing segment is further bifurcated into lab-based pregnancy & ovulation testing, and home-based pregnancy & ovulation testing. Depending on end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. Based on region, womens health diagnostics industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The diagnostic tests segment was the highest contributor to the market in 2020. Increase in prevalence of various health-related disorders among women, such as cancer and infertility, growth in awareness about women’s health-related tests, high demand for point-of-care diagnostic testing, and development of numerous diagnostic & imaging centers drive the women’s health diagnostics market for tests.

By end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. The hospitals and clinics segment was the highest contributor to the market in 2020. The increase in incidence of breast and ovarian cancer has led to a significant rise in the number of hospitalization.

By region, North America constituted the highest womens health diagnostics market share in 2020, owing to numerous technological developments related to diagnosis of women and imaging techniques in this region. Asia-Pacific is projected to grow at the highest CAGR during the womens health diagnostics market forecast, owing to entry of novel tests and kits in the market, and rise in awareness about women’s health diagnostics technology.

KEY FINDINGS OF STUDY

• By type, the diagnostic tests was the highest contributor to the market in 2020.
• By end user, the hospitals & clinics segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
• On the basis of womens health diagnostics market analysis, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.